These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31280139)

  • 1. Nootkatone, an AMPK activator derived from grapefruit, inhibits KRAS downstream pathway and sensitizes non-small-cell lung cancer A549 cells to adriamycin.
    Hung LVM; Moon JY; Ryu JY; Cho SK
    Phytomedicine; 2019 Oct; 63():153000. PubMed ID: 31280139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carnosic Acid against Lung Cancer: Induction of Autophagy and Activation of Sestrin-2/LKB1/AMPK Signalling.
    O'Neill EJ; Sze NSK; MacPherson REK; Tsiani E
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudolaric acid B suppresses NSCLC progression through the ROS/AMPK/mTOR/autophagy signalling pathway.
    Luo D; He F; Liu J; Dong X; Fang M; Liang Y; Chen M; Gui X; Wang W; Zeng L; Fan X; Wu Q
    Biomed Pharmacother; 2024 Jun; 175():116614. PubMed ID: 38670047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin inhibits human non-small cell lung cancer by regulating AMPK-CEBPB-PDL1 signaling pathway.
    Lu T; Li M; Zhao M; Huang Y; Bi G; Liang J; Chen Z; Zheng Y; Xi J; Lin Z; Zhan C; Jiang W; Wang Q; Tan L
    Cancer Immunol Immunother; 2022 Jul; 71(7):1733-1746. PubMed ID: 34837101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvianolic acid F suppresses KRAS-dependent lung cancer cell growth through the PI3K/AKT signaling pathway.
    Hou X; Zhou C; Liang Z; Qiu H; Zhou Z; Zheng H; Li Z; Wang Y; Qi X; Lu L; Cao Y; Zheng J
    Phytomedicine; 2023 Dec; 121():155093. PubMed ID: 37783131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic anticancer effects of ginsenoside CK and gefitinib against gefitinib-resistant NSCLC by regulating the balance of angiogenic factors through HIF-1α/VEGF.
    Song X; Wang L; Cai P; Xu Y; Liu Q; Fan D
    Toxicol Appl Pharmacol; 2024 May; 486():116938. PubMed ID: 38642809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aurora kinase targeting in lung cancer reduces KRAS-induced transformation.
    Dos Santos EO; Carneiro-Lobo TC; Aoki MN; Levantini E; Bassères DS
    Mol Cancer; 2016 Feb; 15():12. PubMed ID: 26842935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin Suppresses Stemness of Non-Small-Cell Lung Cancer Induced by Paclitaxel through FOXO3a.
    Tang Z; Zhang Y; Yu Z; Luo Z
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mogrol-mediated enhancement of radiotherapy sensitivity in non-small cell lung cancer: a mechanistic study.
    Yin Z; Zhang X; Sun X; Huo Y; Ji N; Chen K
    Am J Physiol Cell Physiol; 2024 Jun; 326(6):C1753-C1768. PubMed ID: 38682239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo synergistic anti-tumor effect of LIN28 inhibitor and metformin in oral squamous cell carcinoma.
    Chen H; Sa G; Li L; He S; Wu T
    Eur J Pharmacol; 2021 Jan; 891():173757. PubMed ID: 33249080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer activity of Araguspongine C via inducing apoptosis, and inhibition of oxidative stress, inflammation, and EGFR-TK in human lung cancer cells: An in vitro and in vivo study.
    Li Z; Yu H; Hussain SA; Yang R
    J Biochem Mol Toxicol; 2024 Jul; 38(7):e23763. PubMed ID: 38984790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repurposing of atorvastatin and metformin denotes their individual and combined antiproliferative effects in non-small cell lung cancer.
    Salim EI; Elsebakhy S; Hessien M
    Fundam Clin Pharmacol; 2024 Jun; 38(3):550-560. PubMed ID: 38258539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-non-small cell lung cancer effect of Diosbulbin B: Targeting YY1 induced cell cycle arrest and apoptosis.
    Zhao JQ; Zhou QQ; Sun Y; Yu T; Jiang Y; Li HJ
    Phytomedicine; 2024 Jul; 130():155734. PubMed ID: 38761775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tilianin enhances the antitumor effect of sufentanil on non-small cell lung cancer.
    Chen H; Wu Y; Wang J; Li Y; Chen Y; Wang X; Lv H; Liu X
    J Biochem Mol Toxicol; 2024 Jul; 38(7):e23761. PubMed ID: 38952040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of metformin on breast cancer cell proliferation, the AMPK pathway and the cell cycle.
    Hadad SM; Hardie DG; Appleyard V; Thompson AM
    Clin Transl Oncol; 2014 Aug; 16(8):746-52. PubMed ID: 24338509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapy.
    Ndembe G; Intini I; Moro M; Grasselli C; Panfili A; Panini N; Bleve A; Occhipinti M; Borzi C; Garassino MC; Marabese M; Canesi S; Scanziani E; Sozzi G; Broggini M; Ganzinelli M
    J Exp Clin Cancer Res; 2024 Jan; 43(1):6. PubMed ID: 38163906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SET antagonist enhances the chemosensitivity of non-small cell lung cancer cells by reactivating protein phosphatase 2A.
    Hung MH; Wang CY; Chen YL; Chu PY; Hsiao YJ; Tai WT; Chao TT; Yu HC; Shiau CW; Chen KF
    Oncotarget; 2016 Jan; 7(1):638-55. PubMed ID: 26575017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corosolic acid reduces A549 and PC9 cell proliferation, invasion, and chemoresistance in NSCLC via inducing mitochondrial and liposomal oxidative stress.
    Jin M; Wu Y; Lou Y; Liu X; Dai Y; Yang W; Liu C; Huang G
    Biomed Pharmacother; 2021 Dec; 144():112313. PubMed ID: 34678723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models.
    Svensson RU; Parker SJ; Eichner LJ; Kolar MJ; Wallace M; Brun SN; Lombardo PS; Van Nostrand JL; Hutchins A; Vera L; Gerken L; Greenwood J; Bhat S; Harriman G; Westlin WF; Harwood HJ; Saghatelian A; Kapeller R; Metallo CM; Shaw RJ
    Nat Med; 2016 Oct; 22(10):1108-1119. PubMed ID: 27643638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicine-Assisted Combination Therapy of NSCLC: New Platinum-Based Anticancer Drug Synergizes the Therapeutic Efficacy of Ganetespib.
    Kallu J; Banerjee T; Sulthana S; Darji S; Higginbotham R; Fletcher C; Gerasimchuk NN; Santra S
    Nanotheranostics; 2019; 3(1):120-134. PubMed ID: 30899640
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.